Precigen
PGEN
#5195
Rank
HK$12.16 B
Marketcap
HK$34.39
Share price
6.52%
Change (1 day)
274.36%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2025 (TTM): -HK$1.93 Billion

According to Precigen's latest financial reports the company's current earnings are HK$6.3 Million. In 2024 the company made an earning of -HK$1 Billion a decrease over its 2023 earnings that were of -HK$0.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$1.93 Billion92.63%
2024 -HK$1 Billion32.86%
2023 -HK$0.76 Billion20.5%
2022 -HK$0.63 Billion-23.33%
2021 -HK$0.82 Billion60.11%
2020 -HK$0.51 Billion-65.1%
2019 -HK$1.46 Billion-65.19%
2018 -HK$4.19 Billion313.44%
2017 -HK$1.02 Billion-33.2%
2016 -HK$1.52 Billion123.22%
2015 -HK$0.68 Billion1.47%
2014 -HK$0.67 Billion109.54%
2013 -HK$0.32 Billion-50.04%
2012 -HK$0.64 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novocure
NVCR
-HK$1 Billion-48.56% Jersey
Novavax
NVAX
HK$2.92 B-251.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
-HK$19.39 Million-98.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-HK$0.57 Billion-70.41%๐Ÿ‡ฌ๐Ÿ‡ง UK